EMIS and Graphnet Join Forces for "2015 Consortium" Framework for London and South

EMISEMIS, Graphnet Health and Healthcare Gateway Ltd have formed a strategic alliance to offer clinical information systems and services under the London 2015 initiative, the £300m framework agreement launched by a consortium of 30 NHS Trusts and community organisations in London and the South.

EMIS is one of nine suppliers selected for the framework by the 2015 Consortium and was successful in all three service areas, or 'Lots'. It is both prime contractor and supplier on Lot 1 (the application), Lot 2 (hosting services) and Lot 3 (integration, interoperability, reporting and portal services). Graphnet will be providing its CareCentric products and services for Lot 3, working as a subcontractor to EMIS alongside Healthcare Gateway, which will provide the MIG (Medical Interoperability Gateway) to deliver real-time data exchange between different healthcare systems.

Graphnet and EMIS have worked together successfully for some time. This alliance represents an opportunity to further develop the partnership and integrated working between the companies and their products. This will benefit the 30 Trusts tendering within this framework as well as all other EMIS Web and CareCentric clients across the UK.

EMIS's next generation clinical system EMIS Web was a key part of its bid. The system was specifically designed to deliver cross-organisational integrated healthcare - enabling the secure sharing of clinical information between GPs and community teams across local communities.

Graphnet's CareCentric product suite combines data from large numbers of systems and organisations into a single electronic record and makes it accessible to authorised users across a whole care pathway.

CareCentric already connects to the majority of GP systems and most of the major health and social care IT systems being used in the UK, giving Graphnet substantial experience in integrating large health communities. In Hampshire, for example, CareCentric integrates the data from 157 systems across 9 organisations and 142 GP practices.

Neil Laycock, Managing Director of EMIS, said: "We are delighted to have been successful in all three Lots - demonstrating our ability, together with our partners, to meet the needs of a wide range of healthcare professionals, beyond our heartland of GPs.

"We look forward to the opportunity to use our expertise to help these community and mental health trusts deliver safe, informed and joined-up patient care."

Andy Bratt, managing director of Graphnet, said the 2015 initiative was going to play a major part in driving shared care forward across London and the South. "We are delighted to be part of this strategic alliance and to help deliver the solution set required."

Both Graphnet and EMIS are already well-established in London and the South.

Related news articles:

About EMIS Group plc
EMIS Group plc is the UK's leading supplier of software and related services to GP practices and a major supplier to high street pharmacies. At 31 December 2012, 51.2% of GP practices in the UK have an EMIS system.

The company's transformational healthcare system, EMIS Web, allows different healthcare professionals to share vital information at the point of need. 2,007 GPs are now using EMIS Web as a GP system.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...